Last reviewed · How we verify

Single-dose of cannabis oil — Competitive Intelligence Brief

Single-dose of cannabis oil (Single-dose of cannabis oil) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pain management, Neurology.

phase 3 CB1 and CB2 receptors Pain management, Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Single-dose of cannabis oil (Single-dose of cannabis oil) — Hadassah Medical Organization. Cannabis oil modulates the endocannabinoid system to produce therapeutic effects.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Single-dose of cannabis oil TARGET Single-dose of cannabis oil Hadassah Medical Organization phase 3 CB1 and CB2 receptors
THC/CBD THC/CBD Azienda Ospedaliera Universitaria Policlinico "G. Martino" phase 3 cannabinoid CB1 and CB2 receptors
medical cannabis medical cannabis HaEmek Medical Center, Israel phase 3 CB1 and CB2 receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Single-dose of cannabis oil — Competitive Intelligence Brief. https://druglandscape.com/ci/single-dose-of-cannabis-oil. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: